Gilead Sciences, Inc. (GILD) Presents at Morgan Stanley 23rd Annual Global Healthcare

PresentationTerence FlynnEquity Analyst Great. Well, thanks, everyone, for joining us. I'm Terence Flynn, Morgan Stanley's U.S. biopharma analyst. I'm very pleased to be hosting Gilead this morning. From the company, we have Dan O'Day, the company's Chairman and CEO; and Johanna Mercier, the company's Chief Commercial Officer. Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, pl ...